The HCPLive heart failure page is a resource for medical news and expert insights on HF. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for heart disease, reduced and preserved ejection fraction, and more.
November 18th 2024
A nasal spray form of bumetanide reduced tissue swelling from heart failure as effectively as the oral and intravenous formulations.
November 18th 2024
November 16th 2024
Joseph Alpert: New Technology Provides New Hope for Patient Care
In addition to new medications there are new devices and procedures constantly being developed to help patients across a broad spectrum of conditions. Data from these trials can determine how helpful they are for patients and what their future usage will be.
Joseph Alpert from the University of Arizona: Balancing Patient Needs for Latest Medications
As newer medications are developed for various conditions there can be a rush to prescribe them for patients. However, various factors including cost can make these prohibitive options for doctors and patients alike.
Brooke Worster from Thomas Jefferson University Hospital: Seeing Palliative Care Beyond Hospice
When most people think of palliative care their first thought is likely to hospice and end of life oncology care, but experts in the field are working to change and expand that perception to other areas of health care as well.
Paul Whelton from Tulane University: High Sodium Levels Contributing to Global Health Problems
The intake of sodium is becoming a greater problem across the world, but especially in the United States. While people for the most part are not adding sodium to the food themselves the processed foods they are eating contain more sodium than they did in the past.
It was just three years ago that the American College of Cardiology approved new guidelines regarding lowering cholesterol levels. However, in that time new treatments have been approved necessitating the implementation of new potential methods to help this patient population.
Andrew Tershakovec from Merck: Global Study Looks at Ability to Control Cholesterol Levels Locally
The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.
For many years, warfarin has been the primary option for anticoagulation, but recently newer medications have been approved that may provide better options for this patient population. While the clinical trials of the novel oral anticoagulant drugs showed positive results, there were still lingering questions about how they would fare in the field.